Leaders in media and advertising gathered Thursday night at the 64th Annual Ad Council Public Service Award Dinner. Cheddar's Kristen Scholer spoke with David Fischer, Vice President of Business and Marketing Partnerships at Facebook. Fischer says the explosion in video on social media is impacting the way people consume content on mobile devices. He expects content creators to become more focused on producing content for a mobile-first experience in the future. To date, Facebook has seen its biggest advertising opportunity in its News Feed, but sees an increasing opportunity in the Stories platforms, especially on Instagram. In response to Snap Founder Evan Spiegel's op-ed in Axios this week, Fischer says Facebook's focus is on its own platforms, and creating the experience that works best for people. Fischer says the future of Facebook is all about creating new ways for people to engage with content on its platform.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More